PT  - JOURNAL ARTICLE
AU  - Yang Ge
AU  - Brian Kenneth McKay
AU  - Shengzhi Sun
AU  - Feng Zhang
AU  - Andreas Handel
TI  - Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
AID  - 10.1101/2020.02.20.20025973
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.20.20025973
4099  - http://medrxiv.org/content/early/2020/04/15/2020.02.20.20025973.short
4100  - http://medrxiv.org/content/early/2020/04/15/2020.02.20.20025973.full
AB  - A symptom-based mass screening and testing intervention (MSTI) can identify a large fraction of infected individuals during an infectious disease outbreak. China is currently using this strategy for the COVID-19 outbreak. However, MSTI might lead to increased transmission if not properly implemented. We investigate under which conditions MSTI is beneficial.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fund supporting this research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used previously published data.